Filing Flows › Comparisons › ABEO vs WVE
Abeona Therapeutics vs Wave Life Sciences: ABEO and WVE compared
Abeona Therapeutics is the larger company: $13.5M of revenue in its latest quarter (Q3 2026) against $13.2M for Wave Life Sciences (Q3 2026). Abeona Therapeutics is more profitable, with an operating margin of -96.4% against -502.0%.
Where the money goes: ABEO and WVE
Abeona Therapeutics (ABEO) · Q3 2026
Abeona Therapeutics, Q3 2026: revenue $13.5M, operating margin -96.4%, net loss $4.8M, operating cash flow −$8.3M. The chart follows the revenue to costs, profit and cash.
Wave Life Sciences (WVE) · Q3 2026
Wave Life Sciences, Q3 2026: revenue $13.2M (+73% year over year), operating margin -502.0%, net loss $61.9M, operating cash flow −$60.1M. The chart follows the revenue to costs, profit and cash.
| Abeona Therapeutics (ABEO) | Wave Life Sciences (WVE) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $13.5M | $13.2M |
| Revenue growth, Y/Y | — | +73% |
| Operating margin | -96.4% | -502.0% |
| Net earnings | −$4.8M | −$61.9M |
| Net margin | -35.6% | -470.5% |
| Operating cash flow | −$8.3M | −$60.1M |
Questions
Which is bigger, Abeona Therapeutics or Wave Life Sciences?
Abeona Therapeutics is the larger company: $13.5M of revenue in its latest quarter (Q3 2026) against $13.2M for Wave Life Sciences (Q3 2026).
Is Abeona Therapeutics or Wave Life Sciences growing faster?
Abeona Therapeutics is more profitable, with an operating margin of -96.4% against -502.0%.
More: Abeona Therapeutics earnings · how Abeona Therapeutics makes money · Wave Life Sciences earnings · how Wave Life Sciences makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 9, 2026; 10-Q filed Oct 27, 2026). Fiscal quarters can end on different dates. Not investment advice.